NMN and Jet Lag: Can NAD+ Reset Your Clock?

NMN and Jet Lag is a question that sits at the intersection of circadian biology and cellular metabolism. Travelers crossing multiple time zones experience fatigue, cognitive fog, and sleep disruption because their internal clocks are misaligned with local light-dark cycles. The idea that boosting NAD+ — a coenzyme central to energy metabolism — could help reset that clock has gained traction, but the evidence requires careful scrutiny.

What the Research Actually Shows

Direct human trials testing NMN specifically for jet lag do not exist. The available literature focuses on related outcomes: NAD+ elevation, metabolic health, muscle function, and markers of biological aging. These studies provide the mechanistic scaffolding for the jet lag hypothesis, but they do not constitute proof.

Yoshino et al. (2021) conducted a randomized, double-blind, placebo-controlled trial in 25 postmenopausal women with prediabetes. Participants received 250 mg of NMN daily for ten weeks. The primary outcome was an improvement in muscle insulin sensitivity, measured via hyperinsulinemic-euglycemic clamp. NMN significantly enhanced insulin-stimulated glucose disposal. This matters for jet lag because circadian misalignment itself impairs glucose tolerance — a metabolic stressor that NAD+ modulation might theoretically offset.

Igarashi et al. (2022) randomized 42 healthy older men to 250 mg NMN daily or placebo for 12 weeks. The NMN group showed elevated blood NAD+ levels and improved muscle function metrics including gait speed and grip strength. Notably, the study also observed changes in sleep quality scores, though these were secondary endpoints and not powered for definitive conclusions.

Irie et al. (2020) tested single doses of 100, 250, and 500 mg NMN in healthy Japanese men. Blood NAD+ metabolites rose in a dose-dependent manner within hours, with no adverse effects reported. This pharmacokinetic profile suggests NMN could be taken strategically around travel, though no trial has tested this timing.

Liao et al. (2021) examined NMN in amateur runners at 600–1200 mg daily for six weeks. Aerobic capacity improved in the treatment groups versus placebo. While this is not a jet lag study, it demonstrates that NMN influences physiological systems — oxygen utilization, mitochondrial efficiency — that are compromised by circadian disruption.

Niu et al. (2023) administered 300 mg NMN daily for 90 days to middle-aged adults. They reported changes in serum metabolites, fecal microbiota composition, and telomere length. The telomere finding is exploratory and should be treated with caution, but the metabolic shifts are consistent with NAD+ biology.

Study	Population	Dose & Duration	Design	Relevant Outcome	Jet Lag Direct?
Yoshino 2021	25 prediabetic women	250 mg/day, 10 weeks	RCT, double-blind	Improved muscle insulin sensitivity	No
Igarashi 2022	42 healthy older men	250 mg/day, 12 weeks	RCT, double-blind	Elevated NAD+, improved muscle function, sleep quality signal	No
Irie 2020	10 healthy men	100–500 mg single dose	Open-label, dose-escalation	Dose-dependent NAD+ metabolite rise	No
Liao 2021	48 amateur runners	600–1200 mg/day, 6 weeks	RCT, double-blind	Enhanced aerobic capacity	No
Niu 2023	30 middle-aged adults	300 mg/day, 90 days	RCT, single-blind	Metabolic shifts, exploratory telomere data	No

The Mechanism: NAD+ and the Circadian Clock

Jet lag is fundamentally a circadian disorder. The suprachiasmatic nucleus (SCN) in the hypothalamus governs the master clock, synchronizing peripheral clocks in the liver, muscle, and other tissues to the 24-hour light-dark cycle. When you fly across time zones, these clocks desynchronize. The liver may still be operating on Tokyo time while the SCN attempts to align with New York.

NAD+ sits at a critical node in this system. The coenzyme is not merely a metabolic substrate; it is a signaling molecule. NAD+ serves as the obligate substrate for sirtuins (SIRT1–SIRT7), a family of deacetylases that regulate clock gene expression, and for poly(ADP-ribose) polymerases (PARPs), which participate in DNA repair and stress responses. SIRT1 directly deacetylates core circadian proteins including CLOCK and BMAL1, modulating the amplitude and phase of circadian transcriptional rhythms.

Gomes et al. (2013) demonstrated that declining NAD+ levels during aging disrupt nuclear-mitochondrial communication, creating what they termed a "pseudohypoxic state." This state impairs oxidative metabolism and may exacerbate the metabolic dysfunction seen during circadian misalignment. While this work was conducted in animal models, the conservation of NAD+-sirtuin signaling across mammals makes the findings biologically plausible in humans.

The theoretical chain is therefore: NMN → elevated NAD+ → enhanced sirtuin activity → tighter circadian control → faster re-entrainment after phase shift. Each arrow in that chain is supported by some evidence, but no study has tested the full pathway in a jet lag context. Human data is limited.

What the Evidence Does Not Show

It is essential to be precise about the gaps. No randomized controlled trial has tested NMN against placebo in travelers experiencing jet lag. No study has measured objective markers of circadian re-entrainment — such as dim light melatonin onset (DLMO), core body temperature nadir, or actigraphy-derived sleep efficiency — in NMN-supplemented subjects crossing time zones.

The sleep quality signals in Igarashi et al. (2022) were secondary and underpowered. The metabolic benefits in Yoshino et al. (2021) occurred in a prediabetic population over ten weeks, not in healthy travelers over a few days. The acute NAD+ rise in Irie et al. (2020) tells us NMN reaches circulation quickly, but not whether that translates to faster clock adjustment.

Animal studies on NAD+ and circadian rhythms are more robust. Mouse models show that NAD+ oscillates in a circadian manner, peaking during the active phase, and that manipulating NAD+ levels can shift clock gene expression in peripheral tissues. However, mouse circadian biology differs from human circadian biology in important ways — including the fact that mice are nocturnal. Extrapolation requires caution.

Practical Application: How to Think About NMN for Travel

Given the evidence gaps, what is a rational approach? If you are considering NMN for jet lag, frame it as a metabolic support strategy rather than a circadian cure. Circadian misalignment impairs glucose regulation, increases inflammation, and reduces mitochondrial efficiency. NMN may attenuate some of these effects by maintaining NAD+ availability during a period of physiological stress.

Dosing should align with the human pharmacokinetic data. Irie et al. (2020) showed that 250 mg produces a measurable NAD+ metabolite response, and 500 mg produces a larger one. The chronic studies by Yoshino and Igarashi used 250 mg daily. Liao et al. (2021) used 600–1200 mg for athletic performance, but these higher doses have not been tested for circadian outcomes. For travelers, a conservative approach based on the lower effective doses is more justified by the evidence.

Timing matters theoretically. Because NAD+ levels oscillate with the circadian cycle, taking NMN in the morning of the destination time zone may align better with the intended active phase than taking it at bedtime. This is speculative — no trial has tested it — but it is consistent with the biology of NAD+ rhythmicity.

For those already using NMN as part of a longevity or metabolic health regimen, maintaining supplementation during travel is reasonable. The form and dose you already tolerate is preferable to introducing a new variable mid-travel. Bio:sudo NMN 1000mg provides a single-tablet option at a dose consistent with the upper range studied in human trials, though most circadian-relevant evidence derives from 250–500 mg daily.

Who Benefits Most

The evidence for NMN is strongest in specific populations, and these same groups may derive the most theoretical benefit during travel.

Older adults are the clearest candidates. NAD+ declines with age, and the Igarashi (2022) trial specifically demonstrated benefits in healthy older men. If circadian resilience also declines with age — which it does — then NAD+ repletion may have more room to help.

Individuals with metabolic vulnerability may benefit from the glucose-regulatory effects shown in Yoshino et al. (2021). Jet lag independently worsens insulin sensitivity; maintaining NAD+ levels could buffer this effect.

Frequent travelers who experience repeated circadian disruption may accumulate metabolic and sleep debt. For this group, NMN is best viewed as one component of a broader recovery strategy that includes timed light exposure, melatonin, and sleep hygiene — not a standalone solution.

Healthy young adults with robust circadian systems have the weakest direct evidence for benefit. Their NAD+ levels are already relatively high, and their clocks re-entrain efficiently. For this group, the case for NMN specifically for jet lag is speculative.

Practical Takeaways

• No human trial has directly tested NMN for jet lag; the connection is mechanistic and theoretical.
• NAD+ is a circadian-regulated coenzyme that influences clock gene expression through sirtuins; NMN reliably elevates NAD+ in human studies.
• Doses of 250–500 mg daily have the strongest human evidence for metabolic and muscle outcomes; higher doses have been tested but not for circadian endpoints.
• Older adults and those with metabolic vulnerability have the most plausible theoretical benefit, based on existing trial populations.
• NMN should complement — not replace — established jet lag countermeasures: timed light exposure, strategic sleep scheduling, and melatonin where appropriate.
• For travelers already supplementing with NMN, maintaining dosing across time zones is reasonable; starting NMN solely for jet lag is a lower-evidence decision.

Bottom Line

The hypothesis that NMN can help reset your circadian clock after travel is biologically plausible and grounded in solid mechanistic research, but it remains unproven in human jet lag trials. The available evidence shows that NMN elevates NAD+, improves metabolic and muscle function, and may influence sleep quality — all relevant to the travel experience — yet no study has measured whether travelers recover faster with NMN than without it. If you choose to use it, do so with realistic expectations and as part of a comprehensive circadian resynchronization plan.

References

1. Yoshino M, et al. "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science. 2021;372(6547):1224–1229. [Source]
2. Igarashi M, et al. "Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men." npj Aging. 2022;8(1):5. [Source]
3. Irie J, et al. "Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men." Endocrine Journal. 2020;67(2):153–160. [Source]
4. Liao B, et al. "Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study." Journal of the International Society of Sports Nutrition. 2021;18(1):54. [Source]
5. Gomes AP, et al. "Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging." Cell. 2013;155(7):1624–1638. [Source]
6. Niu KM, et al. "The impacts of short-term NMN supplementation on serum metabolism, fecal microbiota, and telomere length in pre-aging phase." Nutrients. 2023;15(3):755. [Source]

---

---